NanoViricides is trading at $1.31, down 5.07%, with no company-specific explanation for the October 19 decline in available reporting.

  • Its latest listed update was October 16 and concerned ongoing Ebola-trial enrollment progress.
  • Biotech was up 2.09%, and the major indices were mostly higher.
  • No volume or activity details are available, so the cause remains unclear.